Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=167"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=167

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00980005-48fe9545",
        "title": "Flulaval Group vs Fluzone Group: Number of Subjects Reporting Medically Attended Adverse Events (MAEs).",
        "summary": "447 of 1055 against 432 of 1061; risk difference 1.7 points, 95% interval -2.5 to 5.8; NCT00980005, Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children",
        "record": "/library/comparisons/NCT00980005-48fe9545",
        "nct_id": "NCT00980005",
        "kind": "outcome",
        "participants": 2116,
        "risk_difference": {
          "value": 0.016533628741552064,
          "lower": -0.02542267247686221,
          "upper": 0.058411493242981095
        },
        "group_1": "447 of 1,055",
        "group_2": "432 of 1,061",
        "difference": "1.7 points",
        "interval": "-2.5 to 5.8",
        "trial_title": "Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children"
      },
      {
        "id": "NCT00980005-d66edafc",
        "title": "Flulaval Group vs Fluzone Group: Number of Subjects Reporting Serious Adverse Events (SAEs).",
        "summary": "10 of 1055 against 6 of 1061; risk difference 0.4 points, 95% interval -0.4 to 1.2; NCT00980005, Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children",
        "record": "/library/comparisons/NCT00980005-d66edafc",
        "nct_id": "NCT00980005",
        "kind": "outcome",
        "participants": 2116,
        "risk_difference": {
          "value": 0.003823630572963895,
          "lower": -0.004088620372311018,
          "upper": 0.012278317498428469
        },
        "group_1": "10 of 1,055",
        "group_2": "6 of 1,061",
        "difference": "0.4 points",
        "interval": "-0.4 to 1.2",
        "trial_title": "Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=168",
  "request_id": "d7QGC8ss0iiEvrXx"
}